One-dose Pfizer is not happening and here's why
Kaiser explores what the Pfizer vaccine trial data say about a one-dose treatment.
Kaiser Fung
Cutting infection rate by half is not the same as protecting half the people from infection
Kaiser explains what 50% vaccine efficacy actually means, and it's not what you think.
The Swedish mirage: the verdict is already written
Kaiser asks whether we need more time to evaluate Sweden's approach to coronavirus.
I don't like the term herd immunity
Kaiser explains why the term "herd immunity" is problematic
Bloomberg made me digest these graphics slowly
Kaiser enjoys reading the graphics in the Businessweek issue on elections.
Dr. Backlog jumps the pond
Kaiser investigates the official reason for U.K. under-reporting of coronavirus cases.